Seaport Therapeutics, Inc. <SPTX.O>: H.C. Wainwright initiates coverage with buy rating and target price $50
SPTX•Related News
GRAINS-Chicago wheat jumps as Azov Sea attacks threaten Russian exports
WEAT•
Aeva to report Q2 2026 results, host conference call
AEVA•
Manulife Financial Corp <MFC.TO>: Scotiabank raises target price to C$61 from C$56
MFC•
PNC Financial Q2 revenue beats on robust capital markets activity
PNC•
XPLR Infrastructure to report second-quarter results before NYSE open
XIFR•